In addition, it is reported that the use of combined detection of SDC2 and TFPI2 methylation as a new biomarker for a non-invasive tool of CRC will help improve the current dilemma of low early screening rates for CRC (Zhang et al., 2021). Here, SDC2 is linked to colorectal carcinoma.